Hening Lin to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Hening Lin has written about Xenograft Model Antitumor Assays.
Connection Strength
0.375
-
A Mitochondria-Targeting SIRT3 Inhibitor with Activity against Diffuse Large B Cell Lymphoma. J Med Chem. 2024 09 12; 67(17):15428-15437.
Score: 0.190
-
Pharmacological Advantage of SIRT2-Selective versus pan-SIRT1-3 Inhibitors. ACS Chem Biol. 2021 07 16; 16(7):1266-1275.
Score: 0.152
-
Non-oncogene Addiction to SIRT3 Plays a Critical Role in Lymphomagenesis. Cancer Cell. 2019 06 10; 35(6):916-931.e9.
Score: 0.033